Immediate Impact
61 standout
Citing Papers
Mapping the effectiveness and risks of GLP-1 receptor agonists
2025 Standout
Diabetic neuropathy: cutting-edge research and future directions
2025 Standout
Works of Philipp Welschof being referenced
Gliptin and GLP‐1 analog treatment improves survival and vascular inflammation/dysfunction in animals with lipopolysaccharide‐induced endotoxemia
2015
The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Philipp Welschof | 418 | 223 | 50 | 225 | 9 | 644 | |
| Elena Zinßius | 270 | 206 | 37 | 134 | 7 | 584 | |
| Gaetana Albanese | 287 | 232 | 33 | 145 | 11 | 581 | |
| Anna Di Martino | 287 | 232 | 33 | 149 | 13 | 593 | |
| Yoichi Hamada | 268 | 171 | 43 | 141 | 19 | 656 | |
| Alina Hanf | 195 | 180 | 27 | 134 | 6 | 533 | |
| Nobuo Kajitani | 330 | 167 | 63 | 158 | 10 | 628 | |
| Daisuke Yamajuku | 394 | 224 | 21 | 216 | 11 | 704 | |
| Ryo Kodera | 360 | 169 | 68 | 185 | 16 | 632 | |
| Chikage Sato | 279 | 169 | 61 | 144 | 9 | 540 | |
| Yuka Hayashizaki | 575 | 295 | 25 | 311 | 9 | 731 |
All Works
Loading papers...